GlassScriptPhysician profile
Daniel R Latta
NPI 1023456852
$7,796.40
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,321 · 2020: $237 · 2021: $87.61 · 2022: $211 · 2023: $856 · 2024: $83.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $731 · Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $731.08 |
| Food and Beverage | $207.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,011.13 | 2019-2024 | Da Vinci Surgical System |
| Janssen Pharmaceuticals, INC | $157.30 | 2020-2021 | |
| Aroa Biosurgery Incorporated | $141.53 | 2019-2022 | |
| Olympus America INC. | $97.72 | 2019 | |
| Ethicon US, LLC | $78.66 | 2019-2024 | Enseal |
| Stryker Corporation | $39.98 | 2021-2023 | Spy-Phi System |
| Tela Bio, INC. | $35.64 | 2019-2020 | |
| Endologix LLC | $31.30 | 2022 | |
| Bioventus LLC | $29.11 | 2022 | |
| Kerecis Limited | $27.13 | 2022 | |
| Covidien LP | $18.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.83 | 2021 | |
| Teleflex LLC | $18.41 | 2024 | Solesta |
| Smith+Nephew, INC. | $16.29 | 2022 | |
| Abbott Laboratories | $15.80 | 2024 | Esprit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.84 | 2023 | Seglentis |
| Innocoll Pharmaceuticals Limited | $14.58 | 2023 | Xaracoll |
| Baxter Healthcare | $14.20 | 2020 | |
| Lemaitre Vascular, INC. | $9.83 | 2023 | Restoreflow |
| Heron Therapeutics, INC. | $5.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Latta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.